Sana Biotechnology (SANA) Stock Statistics & Valuation Metrics

Sana Biotechnology has a market cap or net worth of $942.94M. The enterprise value is $849.74M.

Sana Biotechnology has 266,366,120 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sana Biotechnology’s return on equity (ROE) is -1.06 and return on invested capital (ROIC) is -58.26%.

The current PE Ratio of Sana Biotechnology is ―. Sana Biotechnology’s PEG ratio is 0.07.

In the last 12 months, Sana Biotechnology had revenue of 0.00 and earned -266.76M in profits. Earnings per share was -1.16.

In the last 12 months, operating cash flow was -158.35M and capital expenditures -501.00K, giving a free cash flow of -158.85M billion.

Sana Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Sana Biotechnology upcoming earnings date is Mar 24, 2026, After Close (Confirmed).

Sana Biotechnology as a current ratio of 3.54, with Debt / Equity ratio of 69.76%

In the past 12 months, Sana Biotechnology has paid 0.00 in taxes.

Sana Biotechnology EV to EBITDA ratio is -1.37, with an EV/FCF ratio of -1.34.

Sana Biotechnology has $153.05M in cash and marketable securities with $89.74M in debt, giving a net cash position of $63.32M billion.

Gross margin is -19.12%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sana Biotechnology is $7.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy